Detalhe da pesquisa
1.
Pharmacologic therapy for nonalcoholic steatohepatitis focusing on pathophysiology.
Yeungnam Univ J Med;
36(2): 67-77, 2019 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31620616
2.
Cilostazol protects hepatocytes against alcohol-induced apoptosis via activation of AMPK pathway.
PLoS One;
14(1): e0211415, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30695051
3.
CD34(+) Liver Cancer Stem Cells Were Formed by Fusion of Hepatobiliary Stem/Progenitor Cells with Hematopoietic Precursor-Derived Myeloid Intermediates.
Stem Cells Dev;
24(21): 2467-78, 2015 Nov 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26192559
4.
Clonogenically Culturing and Expanding CD34+ Liver Cancer Stem Cells in Vitro.
Stem Cells Dev;
24(13): 1506-14, 2015 Jul 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25867583
5.
Identification of cancer stem cell subpopulations of CD34(+) PLC/PRF/5 that result in three types of human liver carcinomas.
Stem Cells Dev;
24(8): 1008-21, 2015 Apr 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25519836
6.
Hepatoma SK Hep-1 cells exhibit characteristics of oncogenic mesenchymal stem cells with highly metastatic capacity.
PLoS One;
9(10): e110744, 2014.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25338121
7.
Cilostazol Decreases Ethanol-Mediated TNFalpha Expression in RAW264.7 Murine Macrophage and in Liver from Binge Drinking Mice.
Korean J Physiol Pharmacol;
16(2): 131-8, 2012 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22563259